In a recent article published in Acta Neuropathologica Communications, a team of researchers from the University of California San Francisco reported a case of a patient with a rapid progressive adult onset scoliosis due to late-onset axial myopathy associated with multiple somatic mtDNA abnormalities but without chronic…

Researchers studied the prenatal diagnostic services provided in the UK for mitochondrial diseases since 2007. The study entitled “A national perspective on prenatal testing for mitochondrial disease” was published on 19 March, 2014 in the European Journal of Human Genetics. Mitochondrial diseases, including mitochondrial…

A recent case report of a patient with acute kidney injury who was later diagnosed with mitochondrial myopathy, titled “Recurrent episodic acute kidney injury as presenting manifestation of mitochondrial myopathy,” is published in the Indian Journal of Nephrology. Mitochondrial cytopathies (MC) are a rare…

Stealth BioTherapeutics, a biopharmaceutical company developing treatments for rare, mitochondria-related diseases, recently announced the initiation of a new clinical study of Bendavia for the treatment of Mitochondrial Myopathy (MM). Mitochondrial Myopathy (MM) is rare genetic condition that affects the mitochondria, a cell’s “center” responsible for maintaining the body’s energy, causing progressive muscle weakness.

As part of its ongoing effort to improve mitochondrial disease patient care, MitoAction — a nonprofit organization dedicated to improving the quality of life for children, adults, and families living with mitochondrial disease through support, education, outreach, advocacy, and clinical research initiatives — in collaboration with the organization’s Medical Advisory Committee…